Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nickel-dependent enzymes are a broad class of metalloenzymes that require nickel as a central cofactor for catalytic activity. Found in archaea, bacteria, plants, and some eukaryotes, they are grouped into redox (e.g., hydrogenase, methyl-coenzyme M reductase) and nonredox enzymes (e.g., urease, glyoxalase I)[1][3][4][6]. Their biological roles span essential cellular processes, such as hydrolysis (e.g., urease breaking down urea), redox transformations in energy metabolism (e.g., [NiFe]-hydrogenase, carbon monoxide dehydrogenase, acetyl-CoA decarbonylase/synthase), and racemization (lactate racemase)[1][3][6]. Nickel-dependent enzymes often display complex active-site architectures, sometimes incorporating nickel as part of a multinuclear metal center or in conjunction with cofactors like the nickel-pincer nucleotide[3][6]. There are at least 14 currently described nickel-dependent enzymes, mostly in prokaryotes. Their expression and activity are tightly regulated due to the potential toxicity of free nickel ions[1][3][4]. While some individual nickel-dependent enzymes (e.g., bacterial urease) are considered validated drug targets—primarily for managing pathogens—no single therapy targets the class as a whole. The entry “Nickel-dependent enzymes” is broad and describes a class/family, not a specific gene or therapeutic target, and thus is not directly suitable as a canonical therapeutic target name[1][3][4][5][6]. Key individual nickel-dependent enzymes include: Urease (hydrolyzes urea; target for anti-ulcer drugs against Helicobacter pylori), [NiFe]-hydrogenase (catalyzes hydrogen oxidation and evolution), Methyl-coenzyme M reductase (final step of methanogenesis), Glyoxalase I, Acireductone dioxygenase, Carbon monoxide dehydrogenase/Acetyl-CoA synthase, Lactate racemase. Each has unique biological relevance and, in some pathogenic cases (e.g., bacterial urease), therapeutic potential[1][2][5][6]. Summary of why "Nickel-dependent enzymes" is not a correct therapeutic target name: This term refers to a class containing many different enzymes with different biological activities and disease associations rather than a specific molecular entity or well-defined target suitable for structured data registries. Where therapeutic relevance exists, it typically refers to specific members of this class, not the whole category[1][3][4][5][6].
Catalysis mediated by coordinated nickel ion(s), enabling redox activity, substrate activation, or isomerization
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nickel-dependent enzyme.